Izmir City Hospital
Izmir, Turkey (Türkiye)
NCT Number: NCT06562595
Cervical cancer represents the fourth most prevalent malignant disease and the fourth leading cause of mortality among women on a global scale. Despite screening and preventive vaccination efforts, cervical cancer remains a significant cause of morbidity and mortality in low- and middle-income countries.
Looking for future studies?
Notify Me18 year and older
Female
Interventional
Not applicable
Izmir, Turkey (Türkiye)
A number of studies have been conducted with the aim of raising awareness about HPV and cervical cancer. However, there is currently no evidence-based consensus on the most effective method of education. The objective of this study is to identify the optimal training method by conducting a randomised controlled trial among healthcare professionals. The training methods under consideration are as follows: 1) Video-based training, 2) Classical lecture training, 3) Brochure, 4) Audio recording (Radio broadcast).
Prior to the commencement of the designated training methods, participants will be required to complete a web-based pre-test. Subsequent to this, the system will automatically assign each participant to a training intervention. Upon completion of the training programme, participants will be required to undertake a second test, the results of which will inform the selection of the most effective training method.
This study will be conducted separately in several distinct healthcare professional groups. Each randomized controlled trial will include 400 participants.
Planned groups include:
Public health nurses
Medical doctors
Medical interns
Midwives
The objective is to identify the most effective educational intervention for improving awareness of HPV and cervical cancer prevention within each group.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Being over 18 and under 40
Exclusion criteria
Training will be provided to the participants, with the objective of determining the most accurate training method on HPV and cervical awareness.
Time frame: After completion of the 25-item assessment tests (first and second test) and training, an average of 1 month.
Participants will first take a test where they will receive a maximum of 25 points and a minimum of 0 points. Then the participants will be automatically assigned to one of the 4 training models, then the trainings will be given and the same test will be applied to the participants again.
By looking at the second test and first test scores, it will be determined which training model increases the participant's score more. Thus, we will be able to understand which form of education increases HPV and cervical awareness in our society.
Time frame: After completion of the 25-item assessment tests (first and second test) and training, an average of 1 month.
Participants will first take a test where they will receive a maximum of 25 points and a minimum of 0 points. Then the participants will be automatically assigned to one of the 4 training models, then the trainings will be given and the same test will be applied to the participants again.
By looking at the second test and first test scores, it will be determined which training model increases the participant's score more. Thus, we will be able to understand which form of education increases HPV and cervical awareness in our society.
Izmir City Hospital
Other Gov
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04679675
Cervical Cancer, Cervical Dysplasia
Seattle, Washington, United States
View Trial DetailsNCT05234112
Cervical Dysplasia, Cervix Cancer
Kakumiro, Uganda
View Trial DetailsNCT07593066
Cervical Cancer, Cervical Intraepithelial Neoplasia
Coyhaique, Aysén, Chile
View Trial DetailsNCT05284877
Cervical Cancer, Cervical Intraepithelial Neoplasia
Copenhagen NV, Capital Region, Denmark
View Trial Details